BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1403800)

  • 21. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice.
    Richardson TA; Morgan ET
    J Pharmacol Exp Ther; 2005 Aug; 314(2):703-9. PubMed ID: 15860574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
    Abdulla D; Goralski KB; Renton KW
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of the male-specific cytochrome P450 3A2 in female rats by phenytoin.
    Ghosal A; Sadrieh N; Reik L; Levin W; Thomas PE
    Arch Biochem Biophys; 1996 Aug; 332(1):153-62. PubMed ID: 8806720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid.
    Knickle LC; Spencer DF; Renton KW
    Biochem Pharmacol; 1992 Aug; 44(3):604-8. PubMed ID: 1380810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes.
    Shimojo N; Ishizaki T; Imaoka S; Funae Y; Fujii S; Okuda K
    Biochem Pharmacol; 1993 Aug; 46(4):621-7. PubMed ID: 8363636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC.
    Morgan ET
    Biochem Pharmacol; 1991 Jun; 42(1):51-7. PubMed ID: 2069598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators.
    Guévin C; Michaud J; Naud J; Leblond FA; Pichette V
    Br J Pharmacol; 2002 Dec; 137(7):1039-46. PubMed ID: 12429576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers.
    Morgan ET; Norman CA
    Drug Metab Dispos; 1990; 18(5):649-53. PubMed ID: 1706245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-related effect of hemin on cytochrome P450 and drug-metabolizing enzymes in rat liver.
    Kobayashi Y; Ohshiro N; Suzuki M; Sasaki T; Tokuyama S; Yoshida T; Yamamoto T
    J Toxicol Sci; 2000 Aug; 25(3):213-22. PubMed ID: 10987129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of xanthine oxidase induction and cytochrome P450 depression during interferon induction in the rat.
    Cribb AE; Renton KW
    Biochem Pharmacol; 1993 Dec; 46(11):2114-7. PubMed ID: 7505583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The microsomal monooxygenase system of regenerating liver. An examination of the role of estradiol in the demasculinization of drug metabolism produced by 2/3 partial hepatectomy.
    Ronis MJ; Lumpkin CK; Thomas PE; Ingelman-Sundberg M; Badger TM
    Biochem Pharmacol; 1992 Feb; 43(3):567-73. PubMed ID: 1540214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of interleukin-1 alpha on rat hepatic cytochrome P450 monooxygenases.
    Sindhu RK; Sakai H; Okamoto T; Kikkawa Y
    Toxicology; 1996 Nov; 114(1):37-46. PubMed ID: 8931759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression, induction and regulation of the cytochrome P450 monooxygenase system in the rat glioma C6 cell line.
    Geng J; Strobel HW
    Brain Res; 1998 Feb; 784(1-2):276-83. PubMed ID: 9518647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretranslational down-regulation of male specific hepatic P450s after portal bypass.
    Jiang XM; Cantrill E; Farrell GC; Murray M
    Biochem Pharmacol; 1994 Aug; 48(4):701-8. PubMed ID: 8080442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressant effects of the interferon inducer polyriboinosinic:polyribocytidylic acid on cytochrome P-450 hemoproteins.
    Zerkle TB; Wade AE
    Pharmacology; 1984; 28(1):1-11. PubMed ID: 6322211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of P450 isozyme-selective inhibitors on in-vitro metabolism of retinoic acid by rat hepatic microsomes.
    Ahmad M; Nicholls PJ; Smith HJ; Ahmadi M
    J Pharm Pharmacol; 2000 Mar; 52(3):311-4. PubMed ID: 10757419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats.
    Masubuchi Y; Kawasaki M; Horie T
    Arch Toxicol; 2006 Jun; 80(6):347-53. PubMed ID: 16485119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.